Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alterity, Apellis, Astellas, Chiesi, CSL, Iveric, Karyopharm, Menarini, Merck, Moderna, Specialised, Teva, Travere, Uniqure.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adimmune, Aileron, Awakn, Biocytogen, Biosenic, Celltrion, Clover, ICER, Ligand, Liscure, Machine Bio, Myeloid, Pregene, Travere.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amniotics, Jasper, Merck, Moderna, NS, Orion, Pfizer, Sarepta, Theriva, Valneva.

New hires and promotions in the biopharma industry, including: Anixa, Brim, Jasper, Novartis, Oxford Biomedica, Preveceutical, Shoreline.

Biopharmas raising money in public or private financings, including: Bavarian Nordic, Checkpoint, Esperas, Mymd, Nfl, Transcode, Verrica.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medtronic, Merit Medical, Terumo Blood and Cell.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: EDX Medical Group, Minerva Surgical, Torax Biosciences, Hologic, Lunit.

Med-tech firms raising money in public or private financings, including: Rhaeos, Volitionrx.

New hires and promotions in the med-tech industry, including: Daxor, Neuronetics.

Year-to-date money raised in public, private and other financings of biopharma companies.